Literature DB >> 10982920

The use of pharmacotherapies for smoking cessation during pregnancy.

N L Benowitz1, D A Dempsey, R L Goldenberg, J R Hughes, P Dolan-Mullen, P L Ogburn, C Oncken, C T Orleans, T A Slotkin, H P Whiteside, S Yaffe.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 10982920      PMCID： PMC1766294          DOI： 10.1136/tc.9.suppl_3.iii91

Source DB:  PubMed          Journal:  Tob Control        ISSN： 0964-4563            Impact factor:   7.552


× No keyword cloud information.
  12 in total

1.  Maternal smoking during pregnancy and evidence-based intervention to promote cessation.

Authors:  P D Mullen
Journal:  Prim Care       Date:  1999-09       Impact factor: 2.907

2.  Smoking cessation guidelines for health professionals. A guide to effective smoking cessation interventions for the health care system. Health Education Authority.

Authors:  M Raw; A McNeill; R West
Journal:  Thorax       Date:  1998-12       Impact factor: 9.139

Review 3.  Nicotine replacement therapy during pregnancy.

Authors:  N L Benowitz
Journal:  JAMA       Date:  1991-12-11       Impact factor: 56.272

Review 4.  Recent advances in the pharmacotherapy of smoking.

Authors:  J R Hughes; M G Goldstein; R D Hurt; S Shiffman
Journal:  JAMA       Date:  1999-01-06       Impact factor: 56.272

5.  Effects of short-term use of nicotine gum in pregnant smokers.

Authors:  C A Oncken; D K Hatsukami; V R Lupo; H A Lando; L M Gibeau; R J Hansen
Journal:  Clin Pharmacol Ther       Date:  1996-06       Impact factor: 6.875

6.  Effects of transdermal nicotine or smoking on nicotine concentrations and maternal-fetal hemodynamics.

Authors:  C A Oncken; H Hardardottir; D K Hatsukami; V R Lupo; J F Rodis; J S Smeltzer
Journal:  Obstet Gynecol       Date:  1997-10       Impact factor: 7.661

7.  Transdermal nicotine replacement in pregnancy: maternal pharmacokinetics and fetal effects.

Authors:  L N Wright; J M Thorp; J A Kuller; R P Shrewsbury; C Ananth; K Hartmann
Journal:  Am J Obstet Gynecol       Date:  1997-05       Impact factor: 8.661

8.  A cost-benefit/cost-effectiveness analysis of smoking cessation for pregnant women.

Authors:  J S Marks; J P Koplan; C J Hogue; M E Dalmat
Journal:  Am J Prev Med       Date:  1990 Sep-Oct       Impact factor: 5.043

9.  The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease.

Authors:  A M Joseph; S M Norman; L H Ferry; A V Prochazka; E C Westman; B G Steele; S E Sherman; M Cleveland; D O Antonuccio; D O Antonnucio; N Hartman; P G McGovern
Journal:  N Engl J Med       Date:  1996-12-12       Impact factor: 91.245

10.  Fetal nicotine or cocaine exposure: which one is worse?

Authors:  T A Slotkin
Journal:  J Pharmacol Exp Ther       Date:  1998-06       Impact factor: 4.030
View more
  18 in total

Review 1.  Helping pregnant smokers quit: meeting the challenge in the next decade.

Authors:  C T Orleans; R W Johnson; D C Barker; N J Kaufman; J F Marx
Journal:  West J Med       Date:  2001-04

Review 2.  Recommendations for the use of pharmacological smoking cessation strategies in pregnant women.

Authors:  Tim Coleman
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 3.  What do we know about the role of pharmacotherapy for smoking cessation before or during pregnancy?

Authors:  Cheryl A Oncken; H R Kranzler
Journal:  Nicotine Tob Res       Date:  2009-08-28       Impact factor: 4.244

4.  Baby BEEP: A randomized controlled trial of nurses' individualized social support for poor rural pregnant smokers.

Authors:  Linda Bullock; Kevin D Everett; Patricia Dolan Mullen; Elizabeth Geden; Daniel R Longo; Richard Madsen
Journal:  Matern Child Health J       Date:  2008-05-22

5.  Transplacental transfer and metabolism of bupropion.

Authors:  Angela D Earhart; Svetlana Patrikeeva; Xiaoming Wang; Doaa Reda Abdelrahman; Gary D V Hankins; Mahmoud S Ahmed; Tatiana Nanovskaya
Journal:  J Matern Fetal Neonatal Med       Date:  2010-05

6.  Early Life Exposure to Nicotine: Postnatal Metabolic, Neurobehavioral and Respiratory Outcomes and the Development of Childhood Cancers.

Authors:  Laiba Jamshed; Genevieve A Perono; Shanza Jamshed; Alison C Holloway
Journal:  Toxicol Sci       Date:  2020-11-01       Impact factor: 4.849

7.  Acceptability of an Internet-based contingency management intervention for smoking cessation: views of smokers, nonsmokers, and healthcare professionals.

Authors:  Bethany R Raiff; Brantley P Jarvis; Marissa Turturici; Jesse Dallery
Journal:  Exp Clin Psychopharmacol       Date:  2013-06       Impact factor: 3.157

8.  Developmental hippocampal neuroplasticity in a model of nicotine replacement therapy during pregnancy and breastfeeding.

Authors:  Ian Mahar; Rosemary C Bagot; Maria Antonietta Davoli; Sharon Miksys; Rachel F Tyndale; Claire-Dominique Walker; Marissa Maheu; Sheng-Hai Huang; Tak Pan Wong; Naguib Mechawar
Journal:  PLoS One       Date:  2012-05-15       Impact factor: 3.240

9.  Pharmacological interventions for promoting smoking cessation during pregnancy.

Authors:  Ravinder Claire; Catherine Chamberlain; Mary-Ann Davey; Sue E Cooper; Ivan Berlin; Jo Leonardi-Bee; Tim Coleman
Journal:  Cochrane Database Syst Rev       Date:  2020-03-04

10.  Recruiting pregnant smokers for a placebo-randomised controlled trial of nicotine replacement therapy.

Authors:  Tim Coleman; Marilyn Antoniak; John Britton; Jim Thornton; Sarah Lewis; Kim Watts
Journal:  BMC Health Serv Res       Date:  2004-11-01       Impact factor: 2.655
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.